Monday, June 16th, 2025

Category: Hong Kong stocks

Li Ning Cautious on 2025 Outlook Despite Revenue Beat in 2024

Li Ning Faces Cautious Outlook Amid Uncertain Environment UOB Kay Hian | March 31, 2025 Li Ning’s 2024 Results: Revenue Beat, Profit Missed Expectations Li Ning, one of the leading sportswear brands in China,...

China Construction Bank Earnings Surpass Expectations, Recapitalization Plan Finalized

China Construction Bank Maintains Solid Performance Despite Headwinds Broker: UOB Kay Hian Date: 31 March 2025 China Construction Bank (CCB), one of China’s leading state-owned banks, has delivered a robust performance in 2024, surpassing...

Pacific Radiance Ltd: The Revival is On Track

Pacific Radiance’s Revival On Track: Charting the Offshore Sector’s Resurgence Phillip Securities Research (Singapore) | March 17, 2025 The offshore services provider Pacific Radiance Ltd. is navigating a steady recovery, as evidenced by its...

Singapore Post Completes Freight Management Holdings Divestment, Invests in eCommerce Logistics Hub

Maybank Research Pte Ltd 28 March 2025 Singapore Post’s Freight Divestment Boosts Efficiency, Sinarmas Land Faces Privatization Offer SingPost Divests Freight Business, Invests in eCommerce Logistics Singapore Post (SingPost) has completed the divestment of...

Jiangsu Horizon Chain Supermarket Company Limited’s (Stock Code: 02625.HK)

Jiangsu Horizon aims to raise funds primarily for growth initiatives, including research and development (R&D) and expansion efforts. The company plans to issue 53,562,000 H Shares, with 5,357,000 allocated to the Hong Kong Public...

💡 Ideas for Investing in China’s Stock Market: From Nio’s Expansion to Dividend-Rich ETFs

NIO-SW (09866.HK) 🔋 Nio’s HK$4 Billion Fundraising Fuels Growth Plans — But Can It Deliver? Chinese electric vehicle giant Nio is hitting the market with a bold share offering — up to 136.8 million...

VISEN Pharmaceuticals’ HK$672 Million IPO: Pioneering Endocrine Therapies in Hong Kong’s Biotech Boom

​Visen Pharmaceuticals, a biopharmaceutical company specializing in endocrinology treatments in China, is set to list on the Hong Kong Stock Exchange under the ticker 02561.HK. The IPO is scheduled for March 21, 2025, aiming...

Keppel REIT Likely to Continue Uptrend – Technical Buy Opportunity

Trendspotter: Comprehensive Analysis of Singapore’s Top Stocks Singapore Retail Research | March 17, 2025 Keppel REIT – Uptrend Continuation Likely Keppel REIT’s technical analysis indicates a bullish continuation. The stock has broken out of...

First Resources (FR SP) – Long term positive despite some short term EPS dilution

Title: Comprehensive Analysis of First Resources and Other Listed Companies in the Region Maybank Research Pte Ltd March 19, 2025 First Resources: Long-term Positive Despite Short-term EPS Dilution Scarcity of Land Justifies the Purchase...

Frencken Group Sees Strong Semi-Con Sales, Maybank Raises Target Price

TITLE: Maybank Research’s Weekly Roundup: Frencken Group Shines, SingPost Unlocks Hidden Value, and Genting Rebounds DATE: 17 March 2025 BROKER: Maybank Research Pte Ltd Frencken Group Ltd – Strong semi-con sales Maybank Research’s channel...